-+ 0.00%
-+ 0.00%
-+ 0.00%

Conexeu Sciences names co-founder David Bogart chief commercial officer

PUBT·06/15/2026 12:31:08
Listen to the news
Conexeu Sciences names co-founder David Bogart chief commercial officer
  • Conexeu named co-founder David Bogart as chief commercial officer, tasking him with commercialization and strategic operations.
  • Bogart is a capital markets adviser and investor-relations strategist who has worked on more than $75 million in capital formation.
  • Three directors joined the board: Kyowa Kirin North America CFO Ana Bastiani-Posner, Lucid Hearing CFO April Burke, RX3 Growth Partners co-managing partner Andrew Costa.
  • Costa previously held investment banking roles at Morgan Stanley, J.P. Morgan; earlier served as a U.S. Air Force captain.
  • Melinda Farina joined the advisory board; she founded Integrated Aesthetics Consulting and Beauty Brokers, advising physicians and aesthetic brands.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Conexeu Sciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606150830PRIMZONEFULLFEED9746846) on June 15, 2026, and is solely responsible for the information contained therein.